Literature DB >> 21931354

Immunotherapy: Seek and destroy: oncolytic virus shows promise in phase I trial.

Christoph A Schmitt.   

Abstract

Year:  2011        PMID： 21931354     DOI： 10.1038/nrclinonc.2011.143

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.

Authors:  Caroline J Breitbach; James Burke; Derek Jonker; Joe Stephenson; Andrew R Haas; Laura Q M Chow; Jorge Nieva; Tae-Ho Hwang; Anne Moon; Richard Patt; Adina Pelusio; Fabrice Le Boeuf; Joe Burns; Laura Evgin; Naomi De Silva; Sara Cvancic; Terri Robertson; Ji-Eun Je; Yeon-Sook Lee; Kelley Parato; Jean-Simon Diallo; Aaron Fenster; Manijeh Daneshmand; John C Bell; David H Kirn
Journal:  Nature       Date:  2011-08-31       Impact factor: 49.962
  1 in total
  2 in total

Review 1.  Novel local therapies in hepatocellular carcinoma.

Authors:  Eleni Liapi; Jean-Francois H Geschwind
Journal:  Clin Liver Dis (Hoboken)       Date:  2013-01-23

2.  Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice.

Authors:  Bin He; Xiuyan Huang; Xinyuan Liu; Bin Xu
Journal:  Mol Biol Rep       Date:  2013-05-11       Impact factor: 2.316
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.